|
Volumn 65, Issue 12 SUPPL. 4, 2005, Pages
|
Advances and limitations in the evaluation of analgesic combination therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALFENTANIL;
ANALGESIC AGENT;
CLONIDINE;
DIPYRONE;
FENTANYL;
KETAMINE;
MORPHINE;
NEOSTIGMINE;
SUFENTANIL;
TRAMADOL;
ANALGESIA;
ANALYTIC METHOD;
CHRONIC PAIN;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADDITIVE EFFECT;
DRUG COMBINATION;
DRUG DOSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FIXED DOSE;
DRUG INTERACTION;
DRUG MEGADOSE;
DRUG POTENTIATION;
DRUG SCREENING;
DRUG SUBADDITIVE EFFECT;
EMPIRICAL RESEARCH;
EXPERIMENTATION;
FACTORIAL DESIGN;
HUMAN;
ISOBOLOGRAM;
LOW DRUG DOSE;
METHODOLOGY;
NONHUMAN;
PATIENT CONTROLLED ANALGESIA;
PLUMMER LASKA METHOD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STANDARD;
STATISTICAL ANALYSIS;
VISUAL AID;
CHRONIC DISEASE;
INTRACTABLE PAIN;
PHYSIOLOGY;
ANALGESICS;
CHRONIC DISEASE;
DATA INTERPRETATION, STATISTICAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION;
DRUG INTERACTIONS;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HUMANS;
PAIN, INTRACTABLE;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 33645049361
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/wnl.65.12_suppl_4.s3 Document Type: Review |
Times cited : (13)
|
References (9)
|